Nads

NADMED is a Finnish diagnostics and life science tools company commercializing assay kits and laboratory services to measure NAD metabolites and glutathione from blood and other biological samples. Its core offering is a CE-marked blood assay kit for NAD+ and NADH, alongside laboratory testing services used in research and clinical settings. The company positions its technology as a simpler, high-throughput alternative to mass spectrometry for quantitative NAD measurement, with applications spanning neurology, oncology, mitochondrial disorders, muscular diseases, fatigue, and Long COVID. NADMED also collaborates with laboratories and clinics internationally and is expanding commercial reach beyond Europe, including into the United States. The business appears to be a diagnostics/tools company rather than a therapeutics developer, so it does not have a traditional drug pipeline.